Hoth Therapeutics is a biopharmaceutical visionary dedicated to finding, investigating and developing early-stage therapeutics that will change the way diseases are managed and treated. Hoth Therapeutics seeks out overlooked drugs that hold the promise to improve treatments and address significant unmet needs for patients. Hoth Therapeutics follows the science to find the ideal indications for each asset and partners with leading companies in the space to bring therapies to market.
Ticker:
HOTH
Exchange:
NASDAQ-CM
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
HT-001 Topical Gel
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
